Page 11 - Secondary Progressive Multiple Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tiziana Life Sciences Ltd : Tiziana Life Sciences Ltd (Tiziana or the Company) - Interim Results for the Six Months Ended 30 June 2022

Advancing pipeline of next generation therapeutics and diagnostics for oncology and immune diseases of high unmet needLONDON, Dec. 27, 2022 (GLOBE NEWSWIRE) Tiziana Life Sciences Ltd ("Tiziana", NASDAQ:

United statesCity ofUnited kingdomKunwar shailubhaiAptar unidoseMatthew davisThomas adamsGabriele cerroneTanuja chitnisTiziana life sciencesTiziana life sciences ltdPatient population expanded access programPatient expanded access ea programLife sciences ltdSecondary progressive multiple sclerosisIndividual patient expanded access

Tiziana Life Sciences Ltd ( Tiziana or the Company ) - Interim Results for the Six Months Ended 30 June 2022

Tiziana Life Sciences Ltd ( Tiziana or the Company ) - Interim Results for the Six Months Ended 30 June 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomKunwar shailubhaiAptar unidoseMatthew davisThomas adamsGabriele cerroneTanuja chitnisTiziana life sciences ltdgabriele cerroneTiziana life sciencesTiziana life sciences ltdPatient population expanded access programPatient expanded access ea programWall streetLife sciences ltd

Tiziana Life Sciences Ltd ( Tiziana or the Company ) - Interim Results for the Six Months Ended 30 June 2022

United statesCity ofUnited kingdomKunwar shailubhaiAptar unidoseMatthew davisThomas adamsGabriele cerroneTanuja chitnisTiziana life sciencesTiziana life sciences ltdPatient population expanded access programPatient expanded access ea programWall streetLife sciences ltdSecondary progressive multiple sclerosis

Tiziana Life Sciences : News Service Announcement, dated November 23, 2022 - Form 6-K

Tiziana Announces Publication of a Peer-Reviewed Article on the Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function and an Induced T Cell Regulatory. | November 23, 2022

New yorkUnited statesWomens hospitalIrina kofflerMatthew davisHana malikIntranasal administration of foralumab demonstrating modulated effectorTiziana life sciencesLifesci advisorsTiziana life sciences ltdHarvard medical schoolBusiness developmentTiziana announces publicationPeer reviewed articleIntranasal administrationForalumab demonstrating modulated effector

Tiziana (TLSA) Announces Article on Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function, Induced T Cell Regulatory Response in Human Subjects

Tiziana (TLSA) Announces Article on Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function, Induced T Cell Regulatory Response in Human Subjects
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Matthew davisTiziana life sciences ltdHarvard medical schoolLife sciencesWomens hospitalHarvard medicalCell sortingChief medical officerSecondary progressive multiple sclerosis